Skip to main content
    Home
    Main navigation
    • Collaboration
    • Analyses
    • v-shop®
    • About us
    • Career
    • Contact
    Login
    Forgot your password?
    Contact
    • German
    • French
    • Italian
    • English
    Login
    Forgot your password?
    Contact
    Back
    rirox | 20525

    Rivaroxaban

    Keywords:
    Bleeding
    Xarelto

    Status

    Material
    Plasma citrate Na-citrate tube, light blue (4)
    Stability
    Stability
    1 day / 18-25°C
    Duration 6 hours
    Frequency 5 x per week (monday - friday)

    Price/Rate

    Price
    Price
    CHF 40.50
    Rate
    Rate
    40.50 TP
    AL Position 1415.00
    Heparine und ähnliche Antikoagulanzien

    Executing laboratory

    External laboratory

    Consultants

    Colucci Giuseppe
    PD, MD
    FMH internal medicine, hematology, FAMH Specialist in laboratory medicine
    T +41 61 486 14 57
    Kalberer Christian
    PhD
    FAMH Specialist in laboratory medicine, main field hematology
    T +41 61 486 15 14
    Hamouda Kaoutar
    MD
    General Medicine, Candidate FAMH Specialist in laboratory medicine, main field medical hematology
    T +41 61 486 15 21
    Redondo Maurice
    MD FMH hematology, FAMH Specialist in laboratory medicine
    Routine laboratories
    T 41 61 486 11 11
    Schleiffenbaum Boris E.
    MD
    FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology
    T +41 76 422 83 00
    Viollier AG

    Hagmattstrasse 14

    4123 Allschwil

    T +41 848 121 121

    Contact | FAQ

    Viollier AG

    Hagmattstrasse 14

    4123 Allschwil

    T +41 848 121 121

    Contact | FAQ

    About us
    • Portrait
    • Locations
    • Job offers
    • Le Vigaro
    About us
    • Portrait
    • Locations
    • Job offers
    • Le Vigaro
    Viollier Apps
    • iOS
    • Android
    Viollier Apps
    • iOS
    • Android
    • SWISS ACCREDITATION sa.admn.ch MTS 0069 Si s

    © 2025 Viollier AG

    Meta navigation EN
    • AGB
    • Nutzungsbedingungen
    • Privacy Policy
    • Rechtliche Hinweise
    • Editorial